Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Why did Roche kill off its Alzheimer's program for the BACE inhibitor RG7129?
Why did Roche kill off its Alzheimer's program for the BACE inhibitor RG7129?
Why did Roche kill off its Alzheimer's program for the BACE inhibitor RG7129?
Submitted by
admin
on December 13, 2013 - 10:51am
Source:
Fierce Biotech
News Tags:
Roche
BACE inhibitors
Alzheimer's disease
RG7129
Headline:
Why did Roche kill off its Alzheimer's program for the BACE inhibitor RG7129?
Do Not Allow Advertisers to Use My Personal information
